Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors - Test2 - elhamkhani - TriplyDB

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors

http://www.wikidata.org/entity/Q28083073

about

Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway.Pharmacogenetics of anthracyclines.Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide damages bone and bone marrow in a female rat model.Perturbation of microRNA signalling by doxorubicin in spermatogonial, Leydig and Sertoli cell lines

P2860

Q33618312-486D13A0-D76B-48D7-88AC-5210DE5207C2 Q38856218-4296153E-253C-4BFA-A06B-3461F2D0C9FA Q47750908-7FBB668D-0655-41AA-B39C-FDDDF9F7A416 Q57497532-B36DD7B0-B0A7-4ADD-9BF6-EE8BA7E56B86

P2860

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors

http://www.wikidata.org/entity/Q28083073

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors

@ast

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors

@en

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors

@nl

type

label

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors

@ast

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors

@en

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors

@nl

prefLabel

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors

@ast

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors

@en

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors

@nl

P1433

Q28083073-81F4CF07-B050-4575-9047-A3375ED627D6

P1476

Q28083073-F701FDE6-8478-40D1-B6CB-E32BA4DE1F85

P2093

Q28083073-CA25C7C3-9900-43F0-8214-07E0169620D4

P275

Q28083073-6E60E245-C48C-481D-9B5D-A3D8594BEE64

P2860

Q28083073-00140EAF-1DE2-49EA-A2A7-B103F4F16D80

Q28083073-0A60E75D-8A56-449D-AB54-C13A7E3B85B6

Q28083073-11F130A7-CDBD-4EC3-9E1D-FB1FC093AAF9

Q28083073-12ECC5CE-9B33-4457-AB10-B6E0468742A6

Q28083073-16EF501F-D355-4241-97F5-9095B182D807

Q28083073-1B57DBFE-0C6A-41DD-B56E-392527DCCD21

Q28083073-1EE0A6F8-5D69-43A8-AA1A-7AB2B5FD6592

Q28083073-21ACA3B3-5003-4C71-8D28-1D2867879E02

Q28083073-21BDA3F4-5084-455B-AB95-B28D3C0CBAD7

Q28083073-2285715D-5CEB-4C78-A733-398917CD064A

P2888

Q28083073-6B5B2E8F-AA40-4940-8B8A-26DFA5CA84A7

P304

Q28083073-1867DA60-DA4D-44D3-9EDD-52EACDE831B5

P31

Q28083073-3D1443CE-889A-43BC-8DF5-5070371E7CD5

Q28083073-61AD4282-E64A-4720-8D8B-4C13D0EF3CC3

P356

Q28083073-37D436E0-0908-4066-8A53-30E53871C2D2

P407

Q28083073-CB45BE4B-0B61-4B06-92A5-E8BB8C3BCA00

P433

Q28083073-7CDC003B-0CE2-4110-B6BF-225A00302EB2

P478

Q28083073-94B49866-7D7E-4647-9293-50AE8FD8B61F

P5008

Q28083073-3707A159-D2BD-4430-8A6B-7C01B3A88146

P577

Q28083073-7ACFBE06-B08D-4618-9D1A-A04F6E03000E

Q28083073-DF104A87-45CE-473D-A700-931385225119

P5875

Q28083073-8B39132A-D45D-4BE1-89DC-8DF96F822247

P6179

Q28083073-B08A2450-AE69-48C1-BFCF-8F529DA11A1A

P698

Q28083073-2453B133-1A13-43E7-8561-B3847E9AE3D1

P921

Q28083073-2C3C6BE4-2636-4E14-B950-45DDFA8A6947

Q28083073-626FE87B-CA17-4AD8-93D5-E27FDD727202

Q28083073-677773D6-89B2-475C-A2B3-965E3CF78C17

Q28083073-68F9A197-FF81-45D0-A6DC-F376BBDDE4FE

Q28083073-94934F17-CFAC-48B9-9655-4F67DAAA3EE8

P932

Q28083073-D37E4A1D-BE27-4010-B47F-16BF74F75382

P356

S00246-015-1176-7

P1433

Pediatric Cardiology

P1476

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors

@en

P2093

Elżbieta Sadurska

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Cancer statistics, 2010

Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Preven

Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer

Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study.

The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy.

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.

Anthracycline cardiotoxicity: from bench to bedside.

Cardiovascular effects in childhood cancer survivors treated with anthracyclines.

P2888

s00246-015-1176-7

P304

1112-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00246-015-1176-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275896430

http://www.w3.org/2001/XMLSchema#string

P6179

1008989671

http://www.w3.org/2001/XMLSchema#string

P698

25939787

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

polycyclic compound

P932

4495714

http://www.w3.org/2001/XMLSchema#string